| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Amoxapine shows atypical antipsychotic effects in patients with schizophrenia: results from a prospective open-label study
|
Apiquian, Rogelio
|
|
2003
|
59 |
1 |
p. 35-39
5 p.
|
article
|
| 2 |
An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia
|
Buchanan, Robert W.
|
|
2003
|
59 |
1 |
p. 29-33
5 p.
|
article
|
| 3 |
A pilot cross-over design study on QTc interval prolongation associated with sulpiride and haloperidol
|
Su, Kuan-Pin
|
|
2003
|
59 |
1 |
p. 93-94
2 p.
|
article
|
| 4 |
Bone mineral density and prolactin associations in patients with chronic schizophrenia
|
Abraham, George
|
|
2003
|
59 |
1 |
p. 17-18
2 p.
|
article
|
| 5 |
Cannabis use and dimensions of psychosis in a nonclinical population of female subjects
|
Verdoux, Hélène
|
|
2003
|
59 |
1 |
p. 77-84
8 p.
|
article
|
| 6 |
Clinical characteristics and associated factors in antipsychotic-induced akathisia of Asian patients with schizophrenia
|
Chong, S.A
|
|
2003
|
59 |
1 |
p. 67-71
5 p.
|
article
|
| 7 |
Clozapine-induced weight gain predicts improvement in psychopathology
|
Meltzer, Herbert Y
|
|
2003
|
59 |
1 |
p. 19-27
9 p.
|
article
|
| 8 |
Editorial Board
|
|
|
2003
|
59 |
1 |
p. IFC-
1 p.
|
article
|
| 9 |
Insight in schizophrenia: associations with executive function and coping style
|
Lysaker, Paul H
|
|
2003
|
59 |
1 |
p. 41-47
7 p.
|
article
|
| 10 |
Negative symptoms and neuroleptics in catatonic schizophrenia
|
Salokangas, Raimo K.R
|
|
2003
|
59 |
1 |
p. 73-76
4 p.
|
article
|
| 11 |
Neurocognitive performance does not correlate with suicidality in schizophrenic and schizoaffective patients at risk for suicide
|
Potkin, Steven G
|
|
2003
|
59 |
1 |
p. 59-66
8 p.
|
article
|
| 12 |
Neuroleptic dose reduction in stable chronic schizophrenia
|
Tsuruta, Satoshi
|
|
2003
|
59 |
1 |
p. 95-96
2 p.
|
article
|
| 13 |
New-onset diabetes and ketoacidosis with atypical antipsychotics
|
Wilson, Daniel R.
|
|
2003
|
59 |
1 |
p. 1-6
6 p.
|
article
|
| 14 |
Placebo response in a double-blind therapeutic supplementation trial in stabilized outpatients with schizophrenia
|
Dickerson, Faith B.
|
|
2003
|
59 |
1 |
p. 97-98
2 p.
|
article
|
| 15 |
Psychosis proneness and ADHD in young relatives of schizophrenia patients
|
Keshavan, Matcheri S.
|
|
2003
|
59 |
1 |
p. 85-92
8 p.
|
article
|
| 16 |
Serum glucose and lipid changes during the course of clozapine treatment: the effect of concurrent β-adrenergic antagonist treatment
|
Baymiller, Scott P
|
|
2003
|
59 |
1 |
p. 49-57
9 p.
|
article
|
| 17 |
The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia
|
Sumiyoshi, Tomiki
|
|
2003
|
59 |
1 |
p. 7-16
10 p.
|
article
|
Journal description